Clinical trial
A Prognostic Study of Sentinel Node and Bone Marrow Micrometastases in Women With Clinical T1-2 N0 Breast Cancer
NCT00003854 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prognostic Study of Sentinel Node and Bone Marrow Micrometastases in Women With Clinical T1-2 N0 Breast Cancer
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 1999
- Completion date
- July 31, 2011
- Enrollment
- 4,590 (actual)
- Sites
- 116
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer